Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-24-007479
Filing Date
2024-06-07
Accepted
2024-06-07 06:02:25
Documents
15
Period of Report
2024-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A zivo_8ka.htm   iXBRL 8-K/A 29512
  Complete submission text file 0001654954-24-007479.txt   155229

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zivo-20240606.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20240606_lab.xml EX-101.LAB 14666
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20240606_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20240606_pre.xml EX-101.PRE 9275
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20240606_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8ka_htm.xml XML 4701
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

EIN.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40449 | Film No.: 241027143
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)